# ENDOTHELION Study Group: Effect of Bosentan in NAION Patients

> **NCT02377271** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 86 (estimated)

## Conditions studied

- Ischemic Optic Neuropathy

## Interventions

- **DRUG:** bosentan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02377271
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2023-12
- **Final completion:** 2025-12
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2022-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02377271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02377271, "ENDOTHELION Study Group: Effect of Bosentan in NAION Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02377271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*